AcquisitionsJul 10, 2026, 02:26 PM
SUIC Acquires 51% of Vision Renu for 30M Shares; New CEO Appointed
AI Summary
SUIC Worldwide Holdings Ltd. has acquired a 51% stake in Taiwan Vision Renu Corporation through a share exchange agreement. The transaction involved 30,000,000 shares of SUIC Common Stock, representing approximately 35% of SUIC's fully-diluted outstanding shares. Following the acquisition, SUIC's Board of Directors was reconstituted, with Chen King Te appointed as Chairman, Director, and CEO, and Shan Hua Peng as Director and CFO. Vision Renu, specializing in high-tech medical devices like a Scleral Micro-Ablation Laser System and a Transcranial Magnetic Stimulation (TMS) device, anticipates significant growth in unit orders over the next three years and plans to enter the life science sector.
Key Highlights
- SUIC acquired 51% of Vision Renu Corporation.
- The acquisition involved an exchange of 30,000,000 shares of SUIC Common Stock.
- These exchange shares represent approximately 35% of SUIC's total outstanding shares on a fully-diluted basis.
- Chen King Te was appointed Chairman, Director, and Chief Executive Officer of SUIC.
- Shan Hua Peng was appointed Director and Chief Financial Officer of SUIC.
- Vision Renu's TMS device has secured hundreds of unit orders across Taiwan and Southeast Asia.
- Vision Renu projects over 150 unit orders for 2026, 500 for 2027, and 5,000 for 2028.
Price Impact
More from SUIC